Genzyme enters research agreement with Cystic Fibrosis
The agreement lays emphasis on identification of compounds known as ‘correctors’ which are believed to aid in the ability of the malfunctioning CFTR protein found in CF patients
US-based biotechnology company Superluminal Medicines has completed a $60m Series B financing round to support its research into therapies for rare genetic forms of obesity and hypothalamic obesity.
Under the collaboration, Healthways will provide its online smoking cessation behavioral support solution QuitNet. GSK’s ‘Blueprint to Quit’ campaign combines Healthways QuitNet solution, including online trained experts, quitting